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Abstract 
Antibiotic resistance is a major global problem, associated with inadvertent drug usage. 
Herbal interventions are a therapeutic strategy that warrants greater research attention. 
Flaxseed and Nigella sativa are well recognized original super foods that have demonstrated 
potent anti-microbial and anti-biofilm activities. In the oral cavity, the bacterial population is a 
result of the dynamic relationship between pathogens and commensals Streptococcus 
pyogenes is an important global human Gram-positive pathogen that causes a wide variety 
of acute infections, it is highly virulent since it has the ability overcome the host defence 
system. This in vitro study aims to evaluate antimicrobial activity of flaxseed and Nigella 
sativa extract against S. pyogenes. Ethanolic extract of flaxseed and Nigella sativa extracts 
were prepared and the minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) against S. pyogenes was estimated. The results of this study show that 
both extracts exhibited antibacterial activity against S. pyogenes. Present study 
demonstrated the bactericidal activity of both extracts which can be an adjunct to the future 
natural anti-bacterial therapy. 
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Introduction 
Nowadays, there is a consumer 
preference for natural products over 
synthetic drugs. One of the main reasons 
for the same is to avoid the adverse 
effects of synthetic medications and the 
risks of bacterial resistance (David & 
Gordon, 2012). In the oral cavity, the 
bacterial population is a result of the 
dynamic relationship between pathogens 
and  commensals   Streptococus 
pyogenes may contribute to many human 
diseases, ranging from mild superficial 
 
 
 
skin infections to life-threatening systemic 
diseases. Infections typically begin in the 
throat or skin. Infections due to certain 
strains of S. pyogenes can be associated 
with the release of bacterial toxins that can 
lead to scarlet fever (Hammer, 2007). 
Other toxigenic S. pyogenes infections 
may lead to streptococcal toxic shock 
syndrome, which can be life-threatening 
(Hammer, 2007). The increase in the 
incidence of invasive S. pyogenes 
infection has frequently been associated 
with specific clones, which raises the 
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possibility that the rise of particularly 
virulent clones was responsible for this re- 
emergence - in particular, the MT1 clone 
which is dominant among invasive S. 
pyogenes isolates in most developed 
countries (Luca-Harari et al., 2009). 
Variation in the distribution may lead to 
fluctuations in the severity of infections 
and in overall mortality rates.  S.  
pyogenes infection may be observed in 
persons of any age, although the 
prevalence of infection is higher in children 
because of the combination of multiple 
exposures (in schools or nurseries, for 
example) and host immunity (Martin et al., 
2004). The prevalence of pharyngeal 
infection is highest in children older than 
three years and has been described as a 
‘hazard’ in school-aged children (Martin et 
al., 2004). Contemporary data suggested 
that invasive S. pyogenes infections 
incidence is around 2 to 4 per 100,000 
population in developed countries (Steer 
et al., 2012). 
Numerous observational studies 
have described the frequencies of 
potential risk or predisposing factors in 
patients with invasive S. 
pyogenes disease, rigorous assessment 
through analytical means have been 
limited. The relative importance of these 
factors may change over time as the 
prevalence of the acute or chronic 
predisposing factors changes in 
frequency, such as influenza activity 
(Zakikhany et al., 2011). Infection of S. 
pyogenes in people lacking of teeth 
causes oral and maxillofacial cellulitis prior 
to sepsis. In this case, S. pyogenes 
originated from sinusitis leaked to oral 
cavity thus, leading to systemic infection 
through wounding of oral cavity mucosal 
lining. The study found that, the risk of 
odontogenic infection still there even 
among edentulous patients (Inagaki et al., 
2017). Penicillin remains the drug of 
choice for the empirical treatment of S. 
pyogenes infection, despite over sixty 
years of use. S. pyogenes has also 
remained uniformly susceptible to 
penicillin and resistance towards penicillin 
or other β-lactams which has been 
approved for the treatment of S. pyogenes 
(Spellerberg & Brandt, 2016). 
Flaxseed and flaxseed oil (also 
called linseed oil) originated from the flax 
plant (Linum usitatissimum). Flaxseed 
protein extracts have demonstrated 
antibacterial activities against most tested 
microorganisms, especially Gram-negative 
bacteria. Meanwhile, flaxseed oil has been 
shown to have antibacterial potential 
against Staphylococcus aureus, 
Pseudomonas aeruginosa, and 
Escherichia coli K-12 (Kaithwas et al., 
2011). Evidently, flaxseed contains the 
highest content of lignin and 
secoisolariciresinol diglucose (SDG) 
among all grains, and is the richest dietary 
source of plant-based SDG (Liggins et al., 
2000; Zhang & Xu, 2007). Flaxseed 
derivatives, such as defatted flaxseed 
meal or flax hulls, have higher 
concentrations (2.3 % and 4 % 
respectively) of SDG (Gaafar et al., 2013). 
Their usage as a dietary supplement is 
becoming more popular nowadays as a 
series of researches have highlighted its 
multitudinous effect on human health. 
However, there are still a lot of ongoing 
studies on the means of optimizing the 
beneficial effects of this called magic plant 
(Pan et al.,2009). 
Nigella  sativa  L. (Ranunculaceae) 
– commonly as “black cumin” – is a 
herbaceous plant that grows in the 
Mediterranean countries and Turkey. It is 
known to have therapeutic potential; in 
fact, sativa-based oils are claimed to have 
potent anti-inflammatory, anticancer, 
antidiabetic, antimicrobial, antihistaminic, 
and antihypotensive effects (Al-Rowais, 
2002; Salem, 2005). N. sativa contains 
many components that have 
pharmaceutical effects such as: 
thymohydroquinone, dithymoquinone, 
thymol, carvacrol, nigellicine, nigellimine- 
x-oxide, nigellidine, and alpha-hedrinhave 
(Aljabre et al., 2005). Thymoquinone is 
one of the main components of N. sativa 
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that has anti-microbial, anti-inflammatory, 
anti-hypertensive, anti-carcinogenic, 
antioxidant, and hepatoprotective effects 
(Tariq, 2008 & Ahmad et al., 2013). 
The present study has been 
conducted to evaluate the antibacterial 
effect of flaxseed and N. sativa extracts 
against S. pyogenes which is believed to 
be resistant to different types of 
antibiotics, the implication of this study will 
be useful in propagating the use of these 
natural based products as therapeutic 
medications. 
Materials and Methods 
Bacterial strains 
Streptococcus pyogenes (ATCC®19615™) 
was used in this study. The cultures as 
obtained from the American Type Culture 
Collection (Manassas, VA, USA). Bacterial 
strain was stored in tryptic soy broth (TSB) 
with 20% glycerol at -80°C and used as 
required. Nutrient agar and nutrient broth 
(Merck) were used to culture the bacterial 
strains. 
Flaxseed and Nigella sativa extracts 
In collaboration with Philadelphia 
University, 500 grams of flaxseeds were 
ground using a dried blender and 
extracted using 99.8% ethanol in a 
Soxhlet chamber. The extract was 
collected and evaporated in a rotary 
evaporator under pressure at 60°C. 
Freeze-drying of the concentrated extracts 
was done for about 30 minutes to remove 
the water residues. The crude extracts 
were stored at 4°C pending further use. 
The extracts of flaxseed were dissolved in 
20% of dimethyl sulfoxide (DMSO) and 
filter-sterilized using a 0.22 µm PES 
syringe filter. The concentrations of the 
flaxseed extracts were 1, 5, 10, 20, 50, 
and 100 mg/ml. All extracts were diluted 
with DMSO to achieve the desired 
concentrations. Similar protocol was 
reflected for N. sativa. 
Antimicrobial sensitivity tests 
Bacterial growth 
The bacteria were cultured on nutrient 
agar and inoculated in nutrient broth. The 
plates were incubated at 37°C for 18 to 48 
hours. For broth media that were 
incubated for 24 hours, 10 µl from the 
bacterial stock was revived at 37°C to be 
used as the inoculum. The turbidity of the 
suspensions were adjusted to 1.5 to 3 x 
108   cells/ml,  which  corresponded  to   an 
absorbance of 0.08 – 0.10 at a wavelength 
of 625 nm (Vanessa Maria Fagundes et 
al., 2014). 
Disk diffusion method 
The sensitivity of S. pyogenes to 
the plant extracts was determined via the 
Kirby-Bauer disk diffusion method 
(Aqueveque et al., 2006; Bauer et al., 
1966; Devi et al., 2011) as well as the 
European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) 
recommendations. The nutrient agar was 
inoculated by swabbing with a sterile 
cotton swab that has been soaked in a 
bacterial broth. With a slight modification 
from previous studies, aqueous extract 
with 100 mg/mL concentration were 
pipetted with different volume (1, 5, 10, 20, 
50 and 100 µl) onto sterile blank discs with 
6 mm diameter (Oxoid, Badhoevedorp, 
Netherlands) and the discs were allowed 
to dry in the biosafety cabinet before being 
impregnated onto agar plate spread with 
inoculum (Revathi & Malathy, 2013). A 
standard antibiotic, penicillin was used as 
positive control for all tested bacteria while 
DMSO was used as negative controls. All 
agar plates were incubated in an incubator 
at 37°C for 18 to 24 hours. The positive 
control was penicillin while the negative 
control was DMSO. Susceptibility testing 
was performed in three biological 
replicates. The plates were observed for 
the presence of an inhibition zone. The 
diameters of the inhibition zones were 
measured (in mm) for each strain, and the 
mean values calculated. The absence of 
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inhibition zone was interpreted as absence 
of antimicrobial activity. 
Statistical Analysis 
The means and standard errors (SE) were 
calculated using Microsoft Excel 2010 
(Microsoft Corporation, Redmond, CA, 
USA). 
Result and Discussion 
In this study, flaxseed and N. sativa 
extracts at concentrations of 5 to 100 
mg/ml inhibited S. pyogenes which was 
similar to the positive control and this in 
line with the finding with Warnke et al., 
(2008). N. sativa showed inhibition zones 
to S. pyogenes at > 20 mg/ml 
concentration. This was similar to Hasan 
et al., (2013) in which the highest 
antimicrobial activity was recorded at 100 
mg/ml. These plant extracts have 
considerable activity against Gram- 
positive bacteria but not Gram-negative 
(Alhaj et al.,2008). 
The biological activities of the 
compounds from the plant extracts 
depend on the type of solvent that was 
used during extraction. The most 
commonly-used solvents were methanol, 
ethanol, and water (Parekh et al., 2009). 
In this study, the inhibition zones produced 
by the flaxseed and N. sativa extracts 
were not very high probably because of 
agro-climate factors, handling of the 
extracts, as well as the phytochemical 
ingredients of the extracts (Erdman et al., 
2007). Most active antimicrobial 
compounds were soluble in polar rather 
than nonpolar solvents (Parekh et al., 
2009). 
We have studied the antimicrobial 
activities of flaxseed and N. sativa extracts 
of various concentrations against S. 
pyogenes. The results are shown in Table 
1. According to Table 1, the diameters of 
the inhibition zones of S. pyogenes in N. 
sativa and flaxseed extracts of 100 mg/ml 
were 6.33 ± 0.33 mm and 6.00 ± 0.0 mm, 
respectively. At the lowest concentration 
of the extracts (1 mg/ml), the diameters 
were 5.67 ± 0.33 mm and 6.00 ± 0.58 mm, 
respectively. The experiments were done 
in triplicates and the results expressed in 
terms of mean ± SE. 
Antibacterial effects were 
demonstrated by the flaxseed extract at 
concentrations ranging from 5 to 10 
mg/ml. From 20 to 100 mg/ml, the 
antibacterial effects of the flaxseed extract 
were the same. Evidently, the lignans of 
flaxseed (secoisolariciresinol) were 
effective against S. aureus and Vibrio sp. 
(Barbary et al., 2010). The N. sativa 
extract showed antibacterial effects at 
concentrations ranging from 1 to 100 
mg/ml. In this study, it was effective 
against S. pyogenes bacteria. Evidently, a 
number of plant-derived compounds are 
more effective against Gram-positive 
bacteria then Gram-negative bacteria 
(Morsi, 2000; Ali et al., 2001; Jones et al., 
2002). 
 
 
Table 1. Inhibition zones of S. pyogenes in Nigella sativa and flaxseed extracts (n=3). 
 
Test Positive Concentration of extract (mg/ml) 
 
extract control 
(mm) 
1 5 10 20 50 100 
Nigella 31.7±1.67 5.67±0.33 5.33±0.33 6.67±1.20 5.67±0.33 6.67±0.33 6.33±0.33 
sativa 
Flaxseed 
 
25.0±2.89 
 
6.00±0.58 
 
6.00±0.00 
 
5.33±0.33 
 
5.33±0.33 
 
5.67±0.33 
 
6.00±0.00 
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The Minimum Inhibitory 
Concentration (MIC) of flaxseed, N. sativa 
extracts were determined using resazurin 
based 96-well plate microdilution method. 
After the incubation period, columns with 
no colour changes (blue resazurin colour 
remain unchanged) were scored as (MIC) 
value. The result showed that N. sativa, 
flaxseed extract shared the same MIC 
which was 12.5 mg/ml on S. pyogenes 
(Table 2). Previous studies reported that 
MIC value for N. sativa extract was 
between <0.25 µg/ml and 1.0 µg/ml of 
Staphylococci species (Ayse et al., 2016 & 
Magdalena et al., 2014). The difference 
may be due to the presence of various 
chemical compounds in this type of extract 
which affect the results of MIC towards S. 
pyogenes, and this may be due to the 
method of isolation and fractionation that 
provides a specific target of bioactive 
compound with antimicrobial properties 
(Shrivastava et al., 2011). The 
antibacterial activity of flaxseed extract is 
associated with its ability to merge with 
bacterial cell wall thus, combating 
bacterial growth. Other than that, the 
existence of long-chain unsaturated fatty 
acids such as alpha linolenic acid and 
linoleic acid might contribute to the 
antimicrobial therapeutic efficacies of 
flaxseed (Barbary et al., 2010). 
 
 
Table 2. Minimum Inhibitory Concentration (MIC) value (mg/ml) on S. pyogenes 
 
Types of Extract 
Nigella sativa Flaxseed Penicillin 
12.5 12.5 25 
 
Conclusion 
In conclusion, flaxseed and Nigella sativa 
extracts have the potential to be 
developed as antibacterial agents against 
S. pyogenes. However, in this study, the 
author suggest that these extracts should 
be explored in vivo to elicit a greater effect 
to the whole organism systems based on 
its toxicity, safe dosage as well as its 
effect on the normal microbiota in the 
future. Further investigations can be 
carried out on the synergestic effect since 
both extracts have good potential to be 
effective antimicrobial agents in the 
medical practice. 
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